Get started
Author

Tanja Schwarz

Observed name: Schwarz, Tanja
ORCID: 0000-0002-6845-5058
Observed ORCID: 0000-0002-6845-5058
OpenAlex ID: A5021658982
Barriers to accessing health care for people with chronic conditions: a qualitative interview study
2022 · Tanja Schwarz, Andrea E. Schmidt, et al. · BMC Health Services Research · 182
PDF
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation
2022 · Tanja Schwarz, Ilonka Horváth, et al. · International Journal of Drug Policy · 61
PDF
Cross-border healthcare collaborations in Europe (2007–2017): Moving towards a European Health Union?
2022 · Andrea E. Schmidt, Julia Bobek, et al. · Health Policy · 26
Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland
2023 · Tanja Schwarz, Judith Anzenberger, et al. · Drug and Alcohol Dependence · 15
Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings
2023 · Ilonka Horváth, Otilia Mårdh, et al. · BMC Health Services Research · 5
PDF
Challenges for the implementation of injectable opioid agonist treatment: a scoping review
2024 · Tanja Schwarz, Deniz Akartuna, et al. · Harm Reduction Journal · 3
PDF
Cohort Profile: The Austrian National Opioid Agonist Treatment Cohort (OAT-AT)
2026 · Tanja Schwarz, Judith Anzenberger, et al. · International Journal of Mental Health and Addiction · 1
PDF
The OPTIMUS International Consensus Guidance for Monitoring User-Reported Outcomes of Opioid Maintenance Treatment: a Delphi Study
2025 · Lucas Wiessing, Deniz Akartuna, et al. · International Journal of Mental Health and Addiction · 1
Sucht: Freiheit im Spannungsfeld ethischer Zielkonflikte
2023 · Martin Busch, Angelina Brotherhood, et al. · Verlag Österreich eBooks · 1
PDF
Mortalität und Todesursachen bei Personen in Opioid-Agonisten-Therapie Ergebnisse aus Österreichs nationaler Kohorte (Teil 1)
2026 · Tanja Schwarz, Judith Anzenberger, et al.
Supplemental Material For : Mortality and causes of death among individuals in a national opioid agonist treatment cohort
2026 · figshare admin karger, Tanja Schwarz, et al. · Figshare
Mortality and Causes of Death among Individuals in a National Opioid Agonist Treatment Cohort
2026 · Tanja Schwarz, Judith Anzenberger, et al. · European Addiction Research
Conducting ethical drug research in prisons: lessons learnt from the implementation of the European Questionnaire on Drug use among People living in Prison (EQDP)
2026 · Linda Montanari, Els Plettinckx, et al. · International Journal of Prison Health
PDF
Corrigendum/Erratum to “Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland” [Drug Alcohol Depend. 254 (2024) 111036]
2025 · Tanja Schwarz, Judith Anzenberger, et al. · Drug and Alcohol Dependence
Repräsentativerhebung zu Konsum‐ und Verhaltensweisen mit Suchtpotenzial: Auswertungen der dritten Erhebungswelle
2024 · Busch, Martin, Puhm, Alexandra, et al. · Fachrepositorium Lebenswissenschaften
Epidemiologiebericht Sucht 2020. Illegale Drogen, Alkohol und Tabak
2020 · Judith Anzenberger, Martin Busch, et al.
Changes of drug use in the general population due to COVID-19
2020 · Martin Busch, Charlotte Klein, et al.
EMCDDA-Trendspotting-Studie über Auswirkungen von COVID-19 auf Menschen mit illegalem Substanzkonsum (PWUD) und auf Einrichtungen der Drogenhilfe in der Europäischen Union
2020 · Ilonka Horváth, Irene Schmutterer, et al.
Works count: 28
Citation count: 295
H-index: 5
I10-index: 4
Year
Topic
Type